We are pleased to be presenting at the first Innate Killer Summit Europe, gathering key European Gamma Delta T, NK, and Macrophage developers with the shared goal of achieving efficacious, off-the-shelf, solid tumour immunotherapies through innate cell targeting and engineering.

This is the first industry-focused meeting spotlighting European expertise within every aspect of innate immune therapy from value chain to fast-track development.

It’s not too late to register and join us in London next month.